🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of the study is to test the efficacy, safety and tolerability...
Status
Completed
Location
1218.6.3302A Boehringer Ingelheim Investigational Site
Start Date
2006-04
Trial ID
NCT00309608
Treatments Being Tested
Study to investigate the safety, tolerability, pharmacokinetics, and pharma...
Status
Completed
Location
Multiple Locations
Start Date
2005-08
Trial ID
NCT02183415
Treatments Being Tested
The objective of the current study is to establish the bioequivalence of li...
Status
Completed
Location
1264.14.1 Boehringer Ingelheim Investigational Site
Start Date
2011-01
Trial ID
NCT01276327
The primary objective of the current study is to investigate the relative b...
Status
Completed
Location
1275.3.1 Boehringer Ingelheim Investigational Site
Start Date
2010-08
Trial ID
NCT01189201
Treatments Being Tested
Study to evaluate the safety, tolerability, pharmacokinetics, and pharmacod...
Status
Completed
Location
Multiple Locations
Start Date
2007-02
Trial ID
NCT02183324
Treatments Being Tested
The objective of the study is to investigate the efficacy and safety of lin...
Status
Completed
Location
1218.62.32003 Boehringer Ingelheim Investigational Site
Start Date
2009-11
Trial ID
NCT01012037
Treatments Being Tested
The data from this study will be used to compare the kinetic profile of met...
Status
Completed
Location
1288.19.1 Boehringer Ingelheim Investigational Site
Start Date
2011-06
Trial ID
NCT01383356
Treatments Being Tested
Study to assess the pharmacokinetics and dose proportionality of 1 mg, 2.5 ...
Status
Completed
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT02183480
Treatments Being Tested